Newsletter
Erythropoietin for TBI, HSCT for severe sickle cell diseaes, everolimus for hepatocellular carcinoma, and more.

JAMA Editor’s Summary

Erythropoietin for TBI, HSCT for severe sickle cell diseaes, everolimus for hepatocellular carcinoma, and more.

Editor's Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the July 02, 2014 issue
July 1, 2014

Erythropoietin for TBI, HSCT for severe sickle cell diseaes, everolimus for hepatocellular carcinoma, and more.

Editor’s Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the July 02, 2014 issue

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

Proudly supported by:

cover
Preventing Blindness with Early Mobile Eye Disease Detection Spect CEO discusses eye disease screenings for early diagnosis and treatment.